434.84MMarket Cap-15500P/E (TTM)
3.1350High2.9200Low541.27KVolume2.9900Open3.0100Pre Close1.66MTurnover0.86%Turnover RatioLossP/E (Static)140.27MShares4.360052wk High8.61P/B194.56MFloat Cap0.920152wk Low--Dividend TTM62.76MShs Float8.4800Historical High--Div YieldTTM7.14%Amplitude0.3010Historical Low3.0580Avg Price1Lot Size
Mereo BioPharma Stock Forum
$Merck & Co(MRK.US)$ x $Immunovant(IMVT.US)$
$Eli Lilly and Co(LLY.US)$ x $Cytokinetics(CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals(REGN.US)$ x $Apellis Pharmaceuticals(APLS.US)$ (panache & brash)
$Gilead Sciences(GILD.US)$ x % $Madrigal Pharmaceuticals(MDGL.US)$ (liver king)
$Bristol-Myers Squibb(BMY.US)$ x $Iovance Biotherapeutics(IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US)$ x $Merus(MRUS.US)$ (partner n...
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
No comment yet